)
Hyderabad-based pharmaceutical major Dr Reddy's Laboratories stated that it has launched amlodipine besylate and atorvastatin calcium tablets, a therapeutic equivalent generic version of Caduet (amlodipine besylate and atorvastatin calcium) tablets, in the US market on March 26, following the approval by the United States Food & Drug Administration (USFDA).
The Caduet tablets brand and generic had US sales of approximately $163 million for the most recent twelve months ending in January 2014, according to IMS Health.
Dr Reddy's tablets are available in bottle counts of 30 and 90, the company stated in a press release on Thursday.
The company's scrip was trading on BSE on Thursday at Rs 2,589, down 1.75% over the previous day's close of Rs 2,636.05.
